Adverum Biotechnologies
ADVM
#9323
Rank
ยฃ70.55 M
Marketcap
ยฃ3.20
Share price
2.16%
Change (1 day)
-28.34%
Change (1 year)

Revenue for Adverum Biotechnologies (ADVM)

Revenue in 2025 (TTM): ยฃ0.74 Million

According to Adverum Biotechnologies 's latest financial reports the company's current revenue (TTM ) is ยฃ0.75 Million. In 2024 the company made a revenue of ยฃ0.79 Million a decrease over the revenue in the year 2023 that were of ยฃ2.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adverum Biotechnologies from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.74 M-6.18%
2024 ยฃ0.79 M-71.8%
2023 ยฃ2.82 M
2022 N/A-100%
2021 ยฃ5.55 M
2020 N/A-100%
2019 ยฃ0.19 M-84.99%
2018 ยฃ1.26 M-7.18%
2017 ยฃ1.36 M16.02%
2016 ยฃ1.17 M-24.65%
2015 ยฃ1.56 M325.93%
2014 ยฃ0.36 M
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA